Congestive heart failure can suddenly worsen (“decompensate”). Call 911 or go to the nearest emergency room if you or someone with heart failure has severe or rapidly worsening shortness of breath — especially at rest or when lying flat, is coughing up pink, frothy sputum, has chest pain or pressure, faints or nearly faints, or has a rapid or very irregular heartbeat with breathlessness. A rapid weight gain from fluid (for example, several pounds over a few days) or new swelling with worsening breathing means you should contact your care team promptly, and seek emergency care if breathing is severe. When in doubt, treat sudden severe breathlessness as an emergency.
Congestive heart failure (CHF) is a chronic condition in which the heart cannot pump efficiently enough to meet the body’s needs, so fluid backs up in the lungs, legs, and abdomen. It is staged from A (at risk) to D (advanced) and split into two main types — reduced (HFrEF) and preserved (HFpEF) ejection fraction. Modern treatment, especially the four medication “pillars,” has transformed outcomes, and daily self-care (weights, sodium and fluid limits, taking medicines exactly as prescribed) prevents most hospitalizations. All medicines here are clinician-directed — never stop or adjust them on your own.
Nearly 6.7 million American adults are living with heart failure. According to the CDC, heart failure was listed on 452,573 death certificates in 2023 — about 14.6% of deaths that year — and it remains a leading cause of hospitalization in people over 65. Despite its name, congestive heart failure does not mean the heart has stopped working. It means the heart can’t pump efficiently enough to meet the body’s needs, so fluid backs up and organs are deprived of adequate blood flow. For more on chronic conditions, see our medical conditions guide. This article is educational and is not a substitute for care from your own clinician.
What Is Congestive Heart Failure?
Heart failure is a chronic, progressive condition in which the heart muscle is too weak, too stiff, or both to pump blood effectively. When the heart can’t keep up with the body’s demands, fluid accumulates — in the lungs (causing shortness of breath), in the legs and abdomen (causing swelling), and in other tissues. This fluid congestion is what gives the condition its full name: congestive heart failure (CHF).
There are two main types based on how the heart is affected. Heart failure with reduced ejection fraction (HFrEF), also called systolic heart failure, occurs when the heart muscle weakens and can’t contract forcefully enough. The ejection fraction (EF) — the percentage of blood pumped out with each beat — drops below the normal range of about 55–70%. Heart failure with preserved ejection fraction (HFpEF), or diastolic heart failure, occurs when the heart muscle becomes stiff and can’t relax properly to fill with blood, even though the pumping strength is preserved. Clinicians also describe an in-between group with “mildly reduced” EF (HFmrEF) and people whose EF recovers on treatment (“improved” EF).
The NHLBI notes that HFpEF now accounts for roughly half of all heart failure cases and is more common in older adults, women, and people with obesity and hypertension. Understanding which type you have matters, because treatments that work well for HFrEF don’t always help HFpEF — though, encouragingly, that gap has narrowed as new research has shown clear benefits for HFpEF too.
Causes
Coronary artery disease is the most common cause of heart failure, responsible for a large share of cases. A heart attack damages or destroys heart muscle, weakening the heart’s pumping ability. Even without a heart attack, chronically reduced blood flow from blocked coronary arteries can weaken the heart over time (ischemic cardiomyopathy).
High blood pressure is the second leading cause. When blood pressure is chronically elevated, the heart must work harder to pump against the increased resistance. Over years, this extra workload causes the heart muscle to thicken, stiffen, and eventually weaken — progressing from compensation to decompensation. Long-standing hypertension is an especially important driver of HFpEF.
Other causes include valvular heart disease (damaged or leaking heart valves), cardiomyopathy (diseases of the heart muscle from alcohol misuse, viral infections, chemotherapy, pregnancy, genetic conditions, or unknown causes), atrial fibrillation (a chronic rapid or irregular rhythm can weaken the heart), diabetes (which directly damages heart muscle), obesity, sleep apnea, thyroid disease, congenital heart defects, and myocarditis (inflammation of the heart). According to the Mayo Clinic, multiple factors often contribute simultaneously, which is why a careful search for reversible causes is part of every evaluation.
Stages and Classification
Heart failure is classified using two complementary systems. The ACC/AHA staging system focuses on disease progression and emphasizes that heart failure can be prevented in its earliest stages:
- Stage A: At risk for heart failure but no structural heart disease or symptoms (for example, someone with hypertension, diabetes, obesity, or coronary artery disease). The goal here is prevention.
- Stage B: Structural heart disease present (such as a reduced EF or valve disease) but no symptoms of heart failure — sometimes called “pre-heart failure.”
- Stage C: Structural heart disease with current or prior symptoms of heart failure.
- Stage D: Advanced heart failure with symptoms that interfere with daily life despite treatment, often requiring specialized interventions (mechanical support, transplant, or palliative care).
The NYHA Functional Classification describes symptom severity:
- Class I: No limitation of physical activity. Ordinary activity doesn’t cause symptoms.
- Class II: Slight limitation. Comfortable at rest, but ordinary activity causes fatigue, palpitations, or shortness of breath.
- Class III: Marked limitation. Comfortable at rest, but less-than-ordinary activity causes symptoms.
- Class IV: Unable to carry out any physical activity without discomfort. Symptoms are present at rest.
Unlike the ACC/AHA stages (which only advance forward), NYHA class can fluctuate — you might move from Class III to Class II with effective treatment. The American Heart Association uses both systems together to guide treatment decisions.
Symptoms
The hallmark symptoms of congestive heart failure reflect fluid congestion and inadequate blood flow. Shortness of breath (dyspnea) is the most common complaint — initially during exertion, then progressively during lighter activities and eventually at rest. Orthopnea (difficulty breathing while lying flat, often relieved by propping up on pillows) and paroxysmal nocturnal dyspnea (waking suddenly at night gasping for breath) occur as fluid shifts to the lungs when you lie down.
Swelling (edema) in the legs, ankles, and feet is caused by fluid retention. It’s often worse at the end of the day and may leave an indentation when you press on the swollen area (pitting edema). Abdominal bloating from fluid accumulation (ascites) causes discomfort and reduced appetite. Rapid weight gain from fluid — for example, 2–3 pounds in a day or about 5 pounds in a week — is a warning sign of worsening congestion and should prompt a call to your care team.
Other symptoms include persistent fatigue, reduced exercise tolerance, a rapid or irregular heartbeat, persistent cough or wheezing (sometimes with pink or blood-tinged mucus), an increased need to urinate at night (nocturia), difficulty concentrating, and decreased appetite with nausea. The Cleveland Clinic emphasizes that symptom awareness and daily self-monitoring — especially daily weights — are essential for catching worsening heart failure early, before it lands you in the hospital.
When to seek emergency care: Call 911 or go to the nearest emergency room for sudden severe shortness of breath, coughing up pink or foamy mucus, chest pain, fainting or severe lightheadedness, or a rapid, irregular heartbeat with shortness of breath. (See the red-flag box at the top of this article.)
Diagnosis
Diagnosis begins with a thorough history and physical examination. Your doctor will listen for abnormal heart sounds (gallops, murmurs), lung crackles indicating fluid, and check for elevated neck veins and leg swelling. Key diagnostic tests include:
Echocardiography is the most important test — a real-time ultrasound of the heart that measures chamber size, wall thickness, valve function, and ejection fraction. It distinguishes HFrEF from HFpEF and identifies underlying structural problems. BNP or NT-proBNP is a blood test; elevated levels indicate the heart is under stress and support a heart failure diagnosis, while low levels make it unlikely.
A chest X-ray can show an enlarged heart and fluid in the lungs. An ECG may reveal rhythm abnormalities, a prior heart attack, or chamber enlargement. Cardiac MRI provides detailed images of heart structure and can identify the cause of a cardiomyopathy. Coronary angiography evaluates for coronary artery disease as an underlying cause. Blood tests for thyroid function, iron, kidney function, and diabetes help find contributing conditions. The NHLBI recommends a comprehensive initial evaluation to identify treatable causes and guide therapy.
Treatment: Medications for HFrEF (the “Four Pillars”)
The treatment of heart failure with reduced ejection fraction has been transformed by what are now called the “four pillars” of guideline-directed medical therapy (GDMT) — four medication classes that each independently reduce hospitalizations and death, and that are generally started together and adjusted over time by your clinician. No doses are given here on purpose: the right medicines, combinations, and amounts are individualized, and they must be set and titrated by your cardiology team.
1. ARNI, ACE inhibitors, or ARBs: These block the renin-angiotensin system, reducing the heart’s workload and slowing disease progression. An ARNI (sacubitril/valsartan, brand name Entresto) is generally preferred over an ACE inhibitor or ARB when tolerated, because it further reduces heart failure hospitalizations and death.
2. Beta-blockers (the heart-failure-specific ones such as carvedilol, metoprolol succinate, or bisoprolol): These slow the heart rate, lower blood pressure, and protect the heart from harmful stress hormones. They improve ejection fraction and reduce mortality in clinical trials.
3. Mineralocorticoid receptor antagonists (MRAs) (spironolactone or eplerenone): These block aldosterone, reducing fluid retention and harmful cardiac remodeling, and they reduce mortality.
4. SGLT2 inhibitors (dapagliflozin or empagliflozin): Originally developed for diabetes, these drugs have shown clear benefits in heart failure regardless of whether a person has diabetes, and they are now a core pillar for HFrEF.
Diuretics (furosemide, bumetanide, torsemide) are used to manage fluid retention and relieve symptoms but don’t improve long-term survival on their own. Hydralazine plus isosorbide dinitrate is an option for people who can’t tolerate the renin-angiotensin drugs and has particular benefit for self-identified Black patients with HFrEF. Other add-on medicines (such as ivabradine or vericiguat) are used in selected situations. The single most important thing to understand: do not stop or change any of these medicines on your own, even if you feel well — stopping GDMT can allow heart failure to worsen quickly. If you have side effects or cost concerns, call your clinician so the plan can be adjusted safely.
Treatment: HFpEF (Preserved Ejection Fraction)
For years there were few proven medicines for HFpEF, but that has changed. SGLT2 inhibitors (empagliflozin and dapagliflozin) are now recommended for HFpEF after trials showed they reduce hospitalizations. An MRA and an ARNI or ARB may also help selected patients. More recently, the newer non-steroidal MRA finerenone and the GLP-1-based medicines used for weight loss (such as semaglutide and tirzepatide) have shown benefit in HFpEF, particularly for people who also have obesity or diabetes. Alongside these, treating the conditions that drive HFpEF — high blood pressure, atrial fibrillation, obesity, sleep apnea, and diabetes — is central. As with HFrEF, all of this is clinician-directed, and which combination is right depends on your individual situation.
Treatment: Devices and Surgery
When medications aren’t sufficient, device-based and surgical interventions may be appropriate. Implantable cardioverter-defibrillators (ICDs) are considered for patients with a persistently low EF (generally 35% or below) despite optimal medical therapy, to prevent sudden cardiac death from dangerous arrhythmias. Cardiac resynchronization therapy (CRT) uses a specialized pacemaker to coordinate the beating of the left and right ventricles, improving efficiency in patients with certain ECG patterns (such as a wide QRS complex with left bundle branch block).
For advanced heart failure unresponsive to standard treatments, left ventricular assist devices (LVADs) — mechanical pumps implanted in the chest — can support the heart as a bridge to transplant or as permanent (“destination”) therapy. Heart transplantation offers the best long-term outcomes for eligible patients with end-stage heart failure, though a shortage of donor organs limits how many can be performed each year.
Valve repair or replacement — increasingly through minimally invasive, catheter-based procedures — may be indicated when valve disease is a contributing factor. The American Heart Association emphasizes that timely referral to an advanced heart failure specialist is important for patients whose condition is deteriorating despite guideline-directed medical therapy. Understanding healthcare costs is relevant when considering advanced heart failure therapies.
Daily Self-Management
Day-to-day management of heart failure depends heavily on you. Daily weight monitoring is one of the most important self-care behaviors — weigh yourself every morning at the same time, after urinating, before eating, wearing similar clothing. A weight gain of 2–3 pounds in a day or about 5 pounds in a week signals fluid retention and should prompt a call to your doctor or an adjustment following your written action plan.
Sodium and fluid limits help control fluid retention, but the specific targets should be set by your clinician rather than assumed — guidance has become more individualized, and overly strict fluid restriction isn’t right for everyone. Medication adherence is critical: taking all prescribed medications consistently is the single most impactful thing you can do. Exercise, while it may seem counterintuitive, is recommended for people with stable heart failure and improves functional capacity and quality of life.
Cardiac rehabilitation is underutilized but highly effective for heart failure patients; research shows it reduces hospitalizations and improves exercise tolerance. Avoiding alcohol (which is directly toxic to heart muscle), quitting smoking, getting recommended vaccinations (including annual flu, plus COVID-19 and pneumococcal and RSV vaccines as advised by your clinician), treating sleep apnea, and monitoring for depression (which is common and worsens outcomes) are all important components of comprehensive self-management.
Frequently Asked Questions
Is congestive heart failure a death sentence?
No. While heart failure is a serious condition, modern treatments have dramatically improved outcomes. Many people with heart failure live active lives for years or even decades after diagnosis. Prognosis depends on the underlying cause, the type and severity, how well the condition responds to treatment, and how consistently you manage it day to day. Getting on the full set of recommended medicines early makes a meaningful difference.
What is the difference between heart failure and a heart attack?
A heart attack is an acute event — a sudden blockage of blood flow to the heart muscle, causing damage. Heart failure is a chronic condition in which the heart gradually loses its ability to pump effectively. A heart attack can cause heart failure by damaging the muscle, but heart failure has many other causes too. Think of a heart attack as a singular event and heart failure as an ongoing state.
Can heart failure be reversed?
In some cases, yes. If the underlying cause is treatable — a reversible cardiomyopathy from alcohol, a correctable valve problem, uncontrolled rapid atrial fibrillation, or a thyroid disorder — the heart can recover substantially. Even in other forms of HFrEF, optimal medical therapy can improve ejection fraction significantly over months. Some people’s EF returns to normal, though they typically need to continue their medicines to maintain the improvement.
How much water can I drink with heart failure?
It depends on the individual. Some people with more severe heart failure are asked to limit total fluids, while many others do not need a strict cap. Your clinician will set specific guidance based on your symptoms, sodium levels, kidney function, and diuretic response — so follow your own plan rather than a general number. Thirst can be managed with ice chips, sugar-free gum or hard candy, or small sips.
Can you exercise with heart failure?
Yes, and you should. Regular, moderate exercise is recommended for people with stable heart failure and improves functional capacity, quality of life, and possibly hospitalization rates. Walking, cycling, and swimming are commonly recommended. Start slowly, increase gradually, and follow your doctor’s or cardiac rehabilitation team’s guidance. Avoid exercising during a flare-up or when symptoms are worsening, and seek care for the red-flag symptoms above.
Living Well With Heart Failure
Heart failure demands a partnership between you and your healthcare team. Know your medications and why you take each one. Monitor your weight and symptoms daily. Follow your clinician’s sodium and fluid guidance. Stay as active as your condition allows. Attend all follow-up appointments, and don’t hesitate to call your doctor when something changes — early intervention prevents hospitalizations.
Build a support system. Heart failure affects not just you but your family and caregivers. Communicate openly about how you’re feeling, both physically and emotionally. Depression and anxiety are common and treatable — addressing them is not a sign of weakness but a smart part of your overall care plan. With the right combination of medical treatment, self-management, and support, many people with heart failure live meaningful, active lives for years after their diagnosis.
This article is general education, not medical advice. Heart failure treatment is individualized and must be directed by your clinician. Do not start, stop, or change any medication or dose on your own. If you have sudden severe shortness of breath, chest pain, pink frothy sputum, fainting, or rapid fluid weight gain, seek emergency care.
Sources
- CDC, About Heart Failure (nearly 6.7 million US adults; 452,573 death certificates / 14.6% of deaths, 2023) — cdc.gov
- NHLBI, Heart Failure — nhlbi.nih.gov/health/heart-failure
- American Heart Association / ACC / HFSA, Heart Failure Guideline — heart.org
- Mayo Clinic, Heart failure — mayoclinic.org
- Cleveland Clinic, Heart Failure — clevelandclinic.org